28 results on '"Oliver, Tim"'
Search Results
2. Mechanical Stabilization of Unbound Layers to Increase Pavement Performance and Incorporation of Benefits into M-E analysis
3. Socio-economic inequalities in testicular cancer survival within two clinical studies
4. Immunity-related GTPase M (IRGM) Proteins Influence the Localization of Guanylate-binding Protein 2 (GBP2) by Modulating Macroautophagy
5. An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent
6. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer
7. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
8. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
9. Local Progression among Men with Conservatively Treated Localized Prostate Cancer: Results from the Transatlantic Prostate Group
10. Integrating FPGA acceleration into HMMer
11. Molecular Positron Emission Tomography and PET/CT Imaging in Urological Malignancies
12. Imaging Hematopoietic Precursor Division in Real Time
13. Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells
14. Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway
15. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma
16. Identification of low oxygen tolerating bacteria in prostate secretions of cancer patients: aetiological and therapeutic relevance
17. Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy.
18. 893 PHASE III STUDY OF INTERMITTENT MONOTHERAPY VS CONTINUOS COMBINED ANDROGEN DEPRIVATION
19. Distinct genomic differences in prostate cancer between Western countries and China
20. PHASE III STUDY OF INTERMITTENT MONOTHERAPY VERSUS CONTINUOUS COMBINED ANDROGEN DEPRIVATION
21. Corrigendum to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I” [Eur Urol 2008;53:478–96] and to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part II” [Eur Urol 2008;53:497–513]
22. EVALUATION OF QUALITY OF LIFE, SIDE EFFECTS AND DURATION OF THERAPY IN A PHASE 3 STUDY OF INTERMMITTENT MONOTHERAPY VERSUS CONTINOUS COMBINED ANDROGEN DEPRIVATION
23. PRE-DIAGNOSTIC PROSTATE SPECIFIC ANTIGEN DYNAMICS DO NOT IMPROVE AN OUTCOME PREDICTION MODEL CONTAINING PROSTATE SPECIFIC ANTIGEN LEVELS ALONE IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER TREATED CONSERVATIVELY OR WITH EARLY HORMONAL THERAPY
24. One-dose carboplatin in seminoma
25. Androgen suppression and irradiation for locally advanced prostate cancer
26. Forces exerted by locomoting cells
27. [40] Design and use of substrata to measure traction forces exerted by cultured cells
28. Treatment of good-risk, stage II, non-seminomatous testis cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.